Your browser doesn't support javascript.
loading
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704.
Regine, William F; Winter, Kathryn; Abrams, Ross A; Safran, Howard; Kessel, Ivan L; Chen, Yuhchyau; Fugazzi, James A; Donnelly, Eric D; DiPetrillo, Thomas A; Narayan, Samir; Plastaras, John P; Gaur, Rakesh; Delouya, Guila; Suh, John H; Meyer, Joshua E; Haddock, Michael G; Didolkar, Mukund S; Padula, Gilbert D A; Johnson, David; Hoffman, John P; Crane, Christopher H.
Affiliation
  • Regine WF; University of Maryland School of Medicine, Baltimore, Maryland.
  • Winter K; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania.
  • Abrams RA; Rush University Medical Center, Chicago, Illinois.
  • Safran H; Rhode Island Hospital, Providence, Rhode Island.
  • Kessel IL; University of Texas Medical Branch, Galveston, Texas.
  • Chen Y; University of Rochester Medical Center, Rochester, New York.
  • Fugazzi JA; Toledo Community Hospital Oncology Program CCOP, Toledo, Ohio.
  • Donnelly ED; Northwestern Memorial Hospital, Chicago, Illinois.
  • DiPetrillo TA; Rhode Island Hospital, Providence, Rhode Island.
  • Narayan S; Michigan Cancer Research Consortium CCOP, Ann Arbor, Michigan.
  • Plastaras JP; University of Pennsylvania Medical Center, Philadelphia, Pennsylvania.
  • Gaur R; Kansas City CCOP, Kansas City, Missouri.
  • Delouya G; Centre Hospitalier de l'Université de Montréal-Notre Dame, Montreal, Quebec.
  • Suh JH; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Meyer JE; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Haddock MG; Mayo Clinic, Rochester, Minnesota.
  • Didolkar MS; Sinai Hospital of Baltimore, Baltimore, Maryland.
  • Padula GDA; Grand Rapids Clinical Oncology Program (GRCOP), Grand Rapids, Michigan.
  • Johnson D; St Francis Regional Medical Center, Wichita, Kansas.
  • Hoffman JP; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Crane CH; The University of Texas MD Anderson Cancer Center, Houston, Texas.
Adv Radiat Oncol ; 3(2): 154-162, 2018.
Article in En | MEDLINE | ID: mdl-29904740

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Adv Radiat Oncol Year: 2018 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Language: En Journal: Adv Radiat Oncol Year: 2018 Document type: Article Country of publication: Estados Unidos